clonidine and atomoxetine hydrochloride

clonidine has been researched along with atomoxetine hydrochloride in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (30.95)	29.6817
2010's	22 (52.38)	24.3611
2020's	7 (16.67)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Biederman, J; Spencer, T; Wilens, T	1
Reeves, G; Schweitzer, J	1
Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A	1
Brown, TE; Evans, SW; Gotlieb, EM; Knight, JR; Ross, EC; Shubiner, HH; Wender, EH; Wibbelsman, CJ; Wilens, T; Wolraich, ML	1
Pritchard, D	2
Arnsten, AF; Biederman, J; Culpepper, L; Doyle, AE; Faraone, SV; Safren, SA; Spencer, TJ; Weiss, MD; Wilens, TE	1
Hamrin, V; Rains, A; Scahill, L	1
Benarroch, F; Gross-Tsur, V; Jaworowski, S	1
Johnston, JA; Pohl, G; Sumner, CR; Van Brunt, DL; Ye, W	1
Wilens, TE	1
Harpin, V; Jamdar, S; Poole, L; Prasad, S; Puvanendran, K; Zeitlin, H	1
Patel, NC; Sears, J	1
Kratochvil, CJ; May, DE	1
Findling, RL; Rowles, BM	1
Bidwell, LC; Kollins, SH; McClernon, FJ	1
Huang, YS; Tsai, MH	1
Hadijikoumi, I; Keen, D	1
García-Bueno, B; Hinojosa, AE; Leza, JC; Madrigal, JL	1
Cavanna, AE; Rickards, H; Worrall, R	1
Chung, K; Duong, S; Wigal, SB	1
Beauchemin, C; Hodgkins, PS; Lachaine, J; Sasane, R	1
Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E	1
Alexander, GC; Conti, RM; Dorsey, ER; Dusetzina, SB; Garfield, CF; Higashi, AS; Huskamp, HA; Kornfield, R; Watson, S	1
Calleja-Pérez, B; Fernández-Jaén, A; Fernández-Perrone, AL; López-Arribas, S; Martín Fernández-Mayoralas, D; Muñoz-Jareño, N	1
Ebbert, JO; Elrashidi, MY	1
Biaggioni, I; Jordan, J; Shibao, C	1
Blumenschein, K; Moga, DC; Sohn, M; Talbert, J	1
Chan, E; Fogler, JM; Hammerness, PG	1
Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y	1
Jain, R; Katic, A	1
Anderson, RH; Mattingly, GW	1
Naguy, A	1
Osland, ST; Pringsheim, T; Steeves, TD	1
Miller, J; Perera, B; Shankar, R	1
Cutler, AJ; Jain, R; Mattingly, GW; O'Neal, W	1
Coghill, D; Cortese, S; Newcorn, JH	1
Feng, HJ; Niu, J; Tan, Z; Zhang, R	1
Dittmann, RW; Krone, B; Newcorn, JH	1
Paric, A; Patterson, B; Pipe, A; Ravindran, AV; Ravindran, N; Van Ameringen, M	1
Buunk, AM; de Boer-Veger, NJ; Deneer, VHM; Guchelaar, HJ; Houwink, EJF; Jama, WOM; Nijenhuis, M; Risselada, A; Rongen, GA; Soree, B; Swen, JJ; Touw, D; van der Weide, J; van Schaik, RHN; van Westrhenen, R	1

Reviews

25 review(s) available for clonidine and atomoxetine hydrochloride

Article	Year
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:1 Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Delayed-Action Preparations; Evidence-Based Medicine; Guanfacine; Humans; Methylphenidate; Propylamines	2004
Pharmacological management of attention-deficit hyperactivity disorder. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6 Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; Methylphenidate; Propylamines	2004
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. Expert opinion on drug safety, 2005, Volume: 4, Issue:2 Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Guanfacine; Humans; Imipramine; Nortriptyline; Propylamines	2005
Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics, 2005, Volume: 115, Issue:6 Topics: Adolescent; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Case Management; Central Nervous System Stimulants; Child; Clonidine; Comorbidity; Continuity of Patient Care; Family Health; Female; Forecasting; Health Services Accessibility; Humans; Insurance Coverage; Intellectual Disability; Male; Mental Disorders; Patient Compliance; Propylamines; Puberty; Risk; Substance-Related Disorders	2005
Attention deficit hyperactivity disorder in children. Clinical evidence, 2005, Issue:13 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy	2005
Mechanism of action of agents used in attention-deficit/hyperactivity disorder. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 8 Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; Nicotinic Antagonists; Pharmacogenetics; Propylamines	2006
Attention deficit hyperactivity disorder in children. Clinical evidence, 2006, Issue:15 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroamphetamine; Humans; Methylphenidate; Propylamines; Psychotherapy	2006
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Developmental disabilities research reviews, 2010, Volume: 16, Issue:3 Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Clinical Trials as Topic; Clonidine; Comorbidity; Developmental Disabilities; Drug Therapy, Combination; Female; Fetal Alcohol Spectrum Disorders; Humans; Intellectual Disability; Male; Methylphenidate; Pregnancy; Propylamines; Psychotropic Drugs	2010
Cognitive enhancers for the treatment of ADHD. Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:2 Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cholinergic Agents; Clonidine; Cognition; Executive Function; Guanfacine; Humans; Intelligence; Methylphenidate; Nootropic Agents; Propylamines; Reward; Social Behavior	2011
Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge. CNS drugs, 2011, Volume: 25, Issue:7 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Delayed-Action Preparations; Guanfacine; Humans; Propylamines; Treatment Outcome	2011
ADHD in children and adolescents. BMJ clinical evidence, 2011, Feb-04, Volume: 2011 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Methylphenidate; Schools	2011
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:5 Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Comorbidity; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Guanfacine; Humans; Methylphenidate; Propylamines	2012
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. Journal of child psychology and psychiatry, and allied disciplines, 2013, Volume: 54, Issue:3 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome	2013
[Autism and attention deficit hyperactivity disorder: pharmacological intervention]. Revista de neurologia, 2013, Sep-06, Volume: 57 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Clonidine; Dopamine Uptake Inhibitors; Drug Evaluation; Guanfacine; Humans; Methylphenidate; Neuroimaging; Propylamines; Psychotropic Drugs; Randomized Controlled Trials as Topic; Treatment Outcome	2013
Emerging drugs for the treatment of tobacco dependence: 2014 update. Expert opinion on emerging drugs, 2014, Volume: 19, Issue:2 Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline	2014
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review. JAMA, 2016, May-10, Volume: 315, Issue:18 Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Delayed-Action Preparations; Guanfacine; Humans; Methylphenidate; Motivation; Psychotherapy; Randomized Controlled Trials as Topic; Social Skills	2016
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments. Molecular neurobiology, 2017, Volume: 54, Issue:9 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Treatment Outcome	2017
Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder. The primary care companion for CNS disorders, 2016, Aug-18, Volume: 18, Issue:4 Topics: Adrenergic Agents; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Clonidine; Guanfacine; Humans; Methylphenidate; Treatment Outcome	2016
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems. CNS spectrums, 2016, Volume: 21, Issue:S1 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Clonidine; Comorbidity; Delayed-Action Preparations; Depressive Disorder; Dextroamphetamine; Guanfacine; Humans; Methylphenidate	2016
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. The Cochrane database of systematic reviews, 2018, 06-26, Volume: 6 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Desipramine; Dextroamphetamine; Female; Guanfacine; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Selegiline; Tic Disorders	2018
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:15 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Cognition; Dextroamphetamine; Humans; Intellectual Disability; Methylphenidate; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2020
Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents. CNS spectrums, 2022, Volume: 27, Issue:2 Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Guanfacine; Humans; United States	2022
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD). CNS drugs, 2021, Volume: 35, Issue:10 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Dextroamphetamine; Drug Resistance; Empirical Research; Humans; Methylphenidate; Randomized Controlled Trials as Topic	2021
Nonstimulant Treatments for ADHD. Child and adolescent psychiatric clinics of North America, 2022, Volume: 31, Issue:3 Topics: Adrenergic alpha-2 Receptor Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Guanfacine; Humans	2022
Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review. Asian journal of psychiatry, 2022, Volume: 76 Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Clonidine; Developing Countries; Humans; Methylphenidate	2022

Trials

1 trial(s) available for clonidine and atomoxetine hydrochloride

Article	Year
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Current medical research and opinion, 2007, Volume: 23, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Therapy, Combination; Female; Headache; Humans; Male; Methylphenidate; Nausea; Propylamines; Prospective Studies; Severity of Illness Index; Treatment Outcome	2007

Article

Year

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

Current medical research and opinion, 2007, Volume: 23, Issue:2

Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Therapy, Combination; Female; Headache; Humans; Male; Methylphenidate; Nausea; Propylamines; Prospective Studies; Severity of Illness Index; Treatment Outcome

2007

Other Studies

16 other study(ies) available for clonidine and atomoxetine hydrochloride

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
New developments in the treatment of ADHD. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1 Topics: Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Cognitive Behavioral Therapy; Guanfacine; Humans; Modafinil; Nicotinic Agonists; Physician's Role; Primary Health Care; Propylamines; Treatment Outcome	2006
Nonstimulant medications for the treatment of ADHD. Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc, 2006, Volume: 19, Issue:1 Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Desipramine; Humans; Propylamines; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors	2006
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:3 Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Humans; Male; Methylphenidate; Propylamines; Tics; Tourette Syndrome	2006
Decreased use of clonidine following treatment with atomoxetine in children with ADHD. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:4 Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Cohort Studies; Drug Utilization Review; Female; Humans; Male; Propylamines; Treatment Outcome	2006
Development of tics in a thirteen-year-old male following atomoxetine use. CNS spectrums, 2008, Volume: 13, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Anticonvulsants; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Clonazepam; Clonidine; Drug Therapy, Combination; Humans; Male; Propylamines; Sympatholytics; Tic Disorders	2008
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy. Drugs, 2010, Volume: 70, Issue:1 Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Half-Life; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Pediatrics; Prodrugs; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: involvement of α2 adrenergic receptors. Brain research bulletin, 2011, Nov-25, Volume: 86, Issue:5-6 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; Animals; Astrocytes; Atomoxetine Hydrochloride; Cells, Cultured; Chemokine CCL2; Clonidine; Cyclic AMP; Desipramine; Isoproterenol; Norepinephrine; Propylamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Yohimbine	2011
Treatment practices in Tourette syndrome: the European perspective. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome	2012
Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective. Postgraduate medicine, 2012, Volume: 124, Issue:3 Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clonidine; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization Review; Female; Guanfacine; Humans; Male; Patient Compliance; Propylamines; Quebec; Retrospective Studies	2012
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatric services (Washington, D.C.), 2013, Apr-01, Volume: 64, Issue:4 Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Clonidine; Dopamine Uptake Inhibitors; Drug Utilization; Guanfacine; Humans; Practice Patterns, Physicians'; Propylamines; United States; United States Food and Drug Administration	2013
Multiple system atrophy: using clinical pharmacology to reveal pathophysiology. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2015, Volume: 25, Issue:1 Topics: Atomoxetine Hydrochloride; Autonomic Nervous System; Clonidine; Diagnosis, Differential; Drug Therapy; Humans; Indole Alkaloids; Multiple System Atrophy; Parkinson Disease; Pure Autonomic Failure; Pyridostigmine Bromide; Trimethaphan	2015
A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy. Attention deficit and hyperactivity disorders, 2016, Volume: 8, Issue:3 Topics: Adolescent; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Cost-Benefit Analysis; Decision Support Techniques; Guanfacine; Health Care Costs; Humans; Monte Carlo Method; Quality-Adjusted Life Years; Treatment Failure	2016
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD. The Journal of nervous and mental disease, 2017, Volume: 205, Issue:9 Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome	2017
Adrenergic α2 receptors are implicated in seizure-induced respiratory arrest in DBA/1 mice. Life sciences, 2021, Nov-01, Volume: 284 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Atomoxetine Hydrochloride; Clonidine; Imidazoles; Mice, Inbred DBA; Receptors, Adrenergic, alpha-2; Respiration; Seizures	2021
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate. European journal of human genetics : EJHG, 2023, Volume: 31, Issue:12 Topics: Atomoxetine Hydrochloride; Catechol O-Methyltransferase; Clonidine; Cytochrome P-450 CYP2D6; Drug Interactions; Humans; Methylphenidate; Pharmacogenetics	2023